Heidi S. Wirtz, PharmD, PhD
Articles
March 16th 2023
Heidi S. Wirtz, PharmD, PhD Zsolt Hepp, PharmD, MSc Simrun Grewal, PhD Phoebe Wright, PharmD, MSc Rupali Fuldeore, MSc Samantha Tomicki, MPH Jared Hirsch, MSc Gabriela Dieguez, MSc L. Johnetta Blakely, MD
Spending on novel therapies in high-risk bladder cancer had minimal impact on Oncology Care Model payments to practices, according to this cohort study and an average performance estimation.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: December 5th 2024 | Updated: December 11th 2024
COVID-19 Infection Increases Risk of Severe Outcomes in Patients With Certain Cardiomyopathies
